New combo offers Chemo-Free hope for older CLL patients
NCT ID NCT02315768
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 30 times
Summary
This study tested a combination of two drugs, ibrutinib and obinutuzumab, in people aged 65 and older with untreated chronic lymphocytic leukemia (CLL) who cannot have chemotherapy. The goal was to see if the combo safely reduces the amount of cancer cells in the body. The trial involved 32 participants and focused on safety and how well the treatment worked.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSD Moores Cancer Center
La Jolla, California, 92093, United States
Conditions
Explore the condition pages connected to this study.